Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Ozone Society is a specialized healthcare organization dedicated to the advancement and clinical application of medical ozone therapy. Founded by leading practitioners Dr. Robert Rowen and Dr. Howard Robins, the society serves as a premier educational hub for healthcare professionals seeking to integrate oxidative medicine into their clinical practice. The organization provides intensive training programs, certification, and standardized protocols for advanced treatments such as Major Autohemotherapy (MAH) and Prolozone. Their mission is to promote the safety and efficacy of ozone-based therapies through peer-to-peer education and the dissemination of clinical research. By fostering a community of trained experts, The Ozone Society aims to expand patient access to alternative treatments for chronic infections and musculoskeletal pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Ozone Society.